Try our beta test site
7 studies found for:    NOONAN SYNDROME 2
Show Display Options
Rank Status Study
1 Completed A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
Condition: Non-infectious Anterior Uveitis
Interventions: Drug: NS2;   Drug: Prednisolone acetate ophthalmic suspension (1%)
2 Completed A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis
Conditions: Allergic Conjunctivitis;   Seasonal Allergies
Interventions: Drug: NS2 Ophthalmic Drops (0.5%);   Drug: NS2 Ophthalmic Drops Vehicle (0.0%)
3 Completed A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)
Condition: Sjögren-Larsson Syndrome
Interventions: Drug: Active topical NS2 1% dermatologic cream;   Drug: Vehicle placebo 0.0% NS2 dermatologic cream
4 Terminated Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome
Condition: Noonan Syndrome
Intervention: Drug: rhIGF-1/rhIGFBP-3
5 Not yet recruiting Hormonal Sensitivity in Patients With Noonan and LEOPARD Syndromes
Conditions: Noonan Syndrome;   LEOPARD Syndrome
Intervention:
6 Completed Study of Metabolic Modifications in Children With Noonan Syndrome
Condition: Child Syndrome
Intervention: Other: Oral Glucose tolerance test
7 Recruiting Familial Investigations of Childhood Cancer Predisposition
Conditions: Acute Leukemia;   Adenomatous Polyposis;   Adrenocortical Carcinoma;   AML;   BAP1 Tumor Predisposition Syndrome;   Carney Complex;   Choroid Plexus Carcinoma;   Constitutional Mismatch Repair Deficiency Syndrome;   Diamond-Blackfan Anemia;   DICER1 Syndrome;   Dyskeratosis Congenita;   Emberger Syndrome;   Familial Acute Myeloid Leukaemia;   Familial Adenomatous Polyposis;   Fanconi Anemia;   Familial Cancer;   Familial Wilms Tumor;   Familial Neuroblastoma;   GIST;   Hereditary Breast and Ovarian Cancer;   Hereditary Paraganglioma-Pheochromocytoma Syndrome;   Hodgkin Lymphoma;   Juvenile Polyposis;   Li-Fraumeni Syndrome;   Lynch Syndrome;   MDS;   Melanoma Syndrome;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Neuroblastoma;   Neurofibromatosis Type 1;   Neurofibromatosis Type II;   Nevoid Basal Cell Carcinoma Syndrome;   Non Hodgkin Lymphoma;   Noonan Syndrome and Other Rasopathy;   Overgrowth Syndromes;   Pancreatic Cancer;   Peutz-Jeghers Syndrome;   Pheochromocytoma/Paraganglioma;   PTEN Hamartoma Tumor Syndrome;   Retinoblastoma;   Rhabdoid Tumor Predisposition Syndrome;   Rhabdomyosarcoma;   Rothmund-Thomson Syndrome;   Tuberous Sclerosis;   Von Hippel-Lindau Disease
Intervention:

Study has passed its completion date and status has not been verified in more than two years.